64 #AHA25 | scientificsessions.org Listings current as of Oct. 17, 2025. Please view the Mobile Meeting Guide App for updates. Saturday, Nov. 8 Disregulated Aldosterone in Uncontrolled Hypertension: The Overlooked Risk Factor and New Therapeutic Options 9:30-10:15 a.m. Heart Theater 1 SPONSOR: Mineralys Therapeutics Introduction to AMVUTTRA® (Vutrisiran) 9:30-10:15 a.m. Learning Studio 1 SPONSOR: Alnylam Pharmaceuticals, Inc. Meet June: A Conversation Between Patient and Cardiologist on Diagnosis, Dialogue and Personal Impact of oHCM 9:30-10:15 a.m. Learning Studio 2 SPONSOR: Cytokinetics, Inc Lipoprotein(a): Actionable Insights for Primary Prevention 9:45-10:15 a.m. Cardio Talk 2 SPONSOR: Eli Lilly and Company ATTR-CM: Evolving Paradigms in Diagnosis and PatientCentered Treatment 11:15 a.m.-12 p.m. Learning Studio 1 SPONSOR: Pfizer Inc From Alerts to Action: How the Apple Watch is Complementing Validated BP Measurement 11:15 a.m.-12 p.m. Heart Theater 2 SPONSOR: AHA/Apple Hypertension Care, Reimagined: The Symplicity™ Blood Pressure Procedure 11:15 a.m.-12 p.m. Heart Theater 1 SPONSOR: Medtronic Real-World Strategies for Lp(a) Testing 11:15 a.m.-12 p.m. Learning Studio 3 SPONSOR: Amgen Inc The Heart of the Matter: Cardiovascular Outcomes With GLP-1RAs 11:15 a.m.-12 p.m. Learning Studio 2 SPONSOR: Novo Nordisk, Inc The Next Beat: A Treatment Option for Patients With Heart Failure (HF) With Left Ventricular Ejection Fraction (LVEF) ≥40% 11:15 a.m.-12 p.m. Learning Studio 4 SPONSOR: Bayer Voices in Lipid Care: Reflections From a Large-Scale Lipid Initiative 11:15 a.m.-12 p.m. Learning Studio 5 SPONSOR: AHA Quality of Care and Outcomes Research Clinical Trial Design for Cardiovascular-KidneyMetabolic (CKM) Health 12:30-1:15 p.m. Heart Theater 2 SPONSOR: AHA Cardiovascular-KidneyMetabolic Syndrome Decoding a Silent Threat: Uncovering Aldosterone’s Impact on Hypertension and Cardiovascular Morbidity 12:30-1:15 p.m. Learning Studio 3 SPONSOR: AstraZeneca Evidence-Based Strategies for the Treatment of Recurrent Pericarditis 12:30-1:15 p.m. Heart Theater 1 SPONSOR: Kiniksa Pharmaceuticals From Evidence Generation to Implementation: Tackling Unmet Need in ASCVD 12:30-1:15 p.m. Learning Studio 5 SPONSOR: Amgen Inc New Frontiers In Cardiology: Opportunities With In Vivo CRISPR-Based Gene Editing 12:30-1:15 p.m. Learning Studio 1 SPONSOR: Intellia Therapeutics, Inc The Conversation We Need: Lp(a), Awareness and Action 12:30-1:15 p.m. Learning Studio 2 SPONSOR: Novartis Pharmaceutical Corporation The Critical Role of Aldosterone in Heart Failure Development and Progression: HFpEF and HFrEF Management 12:30-1:15 p.m. Learning Studio 4 SPONSOR: Boehringer Ingelheim Pharmaceuticals, Inc Beyond Stenosis, Integrating Coronary Inflammation and Plaque Detection in Advanced Cardiac Care 1:45-2:30 p.m. Learning Studio 2 SPONSOR: Caristo Diagnostics The Cardiorenal Connection: How Albuminuria Unveils Hidden Cardiovascular Risk Enabling Early CKD Diagnosis 1:45-2:30 p.m. Learning Studio 1 SPONSOR: Boehringer Ingelheim Pharmaceuticals, Inc The Crossroads of Cardiology and Neurology: A Fireside Chat on Multidisciplinary Care for Multisystem Diseases 1:45-2:30 p.m. Heart Theater 1 SPONSOR: Lexeo Therapeutics, Inc. Understanding ATTR-CM: A Distinct and Treatable Cause of Heart Failure 3:15-4 p.m. Learning Studio 2 SPONSOR: BridgeBio Pharma Obesity: Stories Untold 5-6:30 p.m. New Orleans Theater SPONSOR: Novo Nordisk, Inc. These events are not part of the official Scientific Sessions Conference 2025 as planned by the American Heart Association Committee on Scientific Sessions Programming. Industry Programming Industry Events These events are located in the Science & Technology Hall
RkJQdWJsaXNoZXIy MjI2NjI=